{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:17:39Z","timestamp":1779927459416,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["101019223"],"award-info":[{"award-number":["101019223"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ijpddr.2024.100546","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T14:02:12Z","timestamp":1714917732000},"page":"100546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Robenidine derivatives as potential antischistosomal drug candidates"],"prefix":"10.1016","volume":"25","author":[{"given":"Christian N.","family":"Lotz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Krollenbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Imhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Riscoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0290-3521","authenticated-orcid":false,"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijpddr.2024.100546_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005942","article-title":"Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model","volume":"11","author":"Abla","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.ijpddr.2024.100546_bib2","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1021\/acs.jmedchem.5b01797","article-title":"Robenidine analogues as gram-positive antibacterial agents","volume":"59","author":"Abraham","year":"2016","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijpddr.2024.100546_bib3","first-page":"420","article-title":"Revisiting the General solubility equation: in Silico prediction of aqueous solubility incorporating the effect of topographical polar surface area","volume":"52","author":"Ali","year":"2012","journal-title":"JCIM"},{"key":"10.1016\/j.ijpddr.2024.100546_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-0-12-378612-8.00246-8","article-title":"Veterinary drugs Residues: Coccidiostats","volume":"3","author":"Anad\u00f3n","year":"2014","journal-title":"Encycl. Food Saf."},{"issue":"3","key":"10.1016\/j.ijpddr.2024.100546_bib5","article-title":"Safety and efficacy of Robenz\u00ae 66G (robenidine hydrochloride) for chickens for fattening and turkeys for fattening","volume":"17","author":"Bampidis","year":"2019","journal-title":"EFSA J."},{"issue":"3","key":"10.1016\/j.ijpddr.2024.100546_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijpddr.2014.07.005","article-title":"Serum albumin and \u03b1-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib","volume":"4","author":"Beckmann","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100546_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40249-017-0286-2","article-title":"Controlling schistosomiasis with praziquantel: how much longer without a viable alternative?","volume":"6","author":"Bergquist","year":"2017","journal-title":"Infect. Dis. Poverty"},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100546_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41591-023-02719-4","article-title":"Antimalarial artesunate\u2013mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial","volume":"30","author":"Bottieau","year":"2024","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100546_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0163-7258(95)00026-7","article-title":"Antischistosomal drugs: past, present and future?","volume":"68","author":"Cioli","year":"1995","journal-title":"Pharmacol. Ther."},{"issue":"9936","key":"10.1016\/j.ijpddr.2024.100546_bib10","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100546_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijpddr.2024.100546_bib12","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/ci034243x","article-title":"ESOL: estimating aqueous solubility directly from molecular structure","volume":"44","author":"Delaney","year":"2004","journal-title":"J. Chem. Inf. Comput."},{"issue":"5","key":"10.1016\/j.ijpddr.2024.100546_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0035-9203(02)90405-0","article-title":"Resistance of Schistosoma mansoni to praziquantel: is there a problem?","volume":"96","author":"Doenhoff","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.ijpddr.2024.100546_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1039\/D0MD00062K","article-title":"Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?","volume":"11","author":"Dziwornu","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ijpddr.2024.100546_bib15","series-title":"Parasitic Helminths and Zoonoses-From Basic to Applied Research","article-title":"Recent advances in anti-schistosomiasis drug discovery","author":"Ezra","year":"2022"},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100546_bib16","first-page":"83","article-title":"Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific","volume":"51","author":"Fallon","year":"1994","journal-title":"ASTMH"},{"issue":"12","key":"10.1016\/j.ijpddr.2024.100546_bib17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4155\/fmc.13.113","article-title":"Hemozoin and antimalarial drug discovery","volume":"5","author":"Fong","year":"2013","journal-title":"Future Med. Chem."},{"issue":"4","key":"10.1016\/j.ijpddr.2024.100546_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.618","article-title":"In vitro and in vivo human metabolism and pharmacokinetics of S\u2010 and R\u2010praziquantel","volume":"8","author":"Kapungu","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100546_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000350","article-title":"Mefloquine\u2014an aminoalcohol with promising antischistosomal properties in mice","volume":"3","author":"Keiser","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"24","key":"10.1016\/j.ijpddr.2024.100546_bib20","first-page":"3531","article-title":"Antimalarials in the treatment of schistosomiasis","volume":"18","author":"Keiser","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijpddr.2024.100546_bib21","series-title":"Drug-like Properties: Concepts, Structure Design, and Methods","first-page":"3","author":"Kerns","year":"2008"},{"key":"10.1016\/j.ijpddr.2024.100546_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fmicb.2019.00837","article-title":"In vitro antimicrobial activity of robenidine, ethylenediaminetetraacetic acid and polymyxin B nonapeptide against important human and veterinary pathogens","volume":"10","author":"Khazandi","year":"2019","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.ijpddr.2024.100546_bib23","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1021\/acsinfecdis.1c00001","article-title":"Robenidine analogues are potent antimalarials in drug-resistant Plasmodium falciparum","volume":"7","author":"Krollenbrock","year":"2021","journal-title":"ACS Infect. Dis."},{"issue":"2","key":"10.1016\/j.ijpddr.2024.100546_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41596-018-0101-y","article-title":"Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni","volume":"14","author":"Lombardo","year":"2019","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.ijpddr.2024.100546_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00436-001-0511-5","article-title":"An anti-contamination cocktail for the in vitro isolation and cultivation of parasitic protozoa","volume":"88","author":"M\u00e4ser","year":"2002","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.ijpddr.2024.100546_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"McManus","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijpddr.2024.100546_bib27","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3389\/fmicb.2020.00996","article-title":"FDA approved drug library screening identifies robenidine as a repositionable antifungal","volume":"11","author":"Mei","year":"2020","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.ijpddr.2024.100546_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpddr.2014.07.002","article-title":"Repurposing drugs for the treatment and control of helminth infections","volume":"4","author":"Panic","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2024.100546_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.apar.2022.05.002","article-title":"Improving translational power in antischistosomal drug discovery","volume":"117","author":"Probst","year":"2022","journal-title":"Adv. Parasitol."},{"issue":"5","key":"10.1016\/j.ijpddr.2024.100546_bib30","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1021\/acsinfecdis.0c00278","article-title":"Expanding the activity profile of pyrido[1,2-a]benzimidazoles: synthesis and evaluation of novel N1-1-phenylethanamine derivatives against Schistosoma mansoni","volume":"7","author":"Probst","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2024.100546_bib31","first-page":"193","article-title":"Serum albumin: clinical significance of drug binding and development as drug delivery vehicle","volume":"123","author":"Tayyab","year":"2021","journal-title":"Adv. Protein Chem. Strct."},{"key":"10.1016\/j.ijpddr.2024.100546_bib32","article-title":"OpenVirtualToxLab\u2014a platform for generating and exchanging in silico toxicity data","volume":"232","author":"Vedani","year":"2014","journal-title":"Toxicol. Lett."},{"issue":"5","key":"10.1016\/j.ijpddr.2024.100546_bib33","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis: a review","volume":"111","author":"Wang","year":"2012","journal-title":"Parasitol. Res."},{"issue":"4","key":"10.1016\/j.ijpddr.2024.100546_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpara.2016.10.005","article-title":"Schistosoma hemozoin and its possible roles","volume":"47","author":"Xiao","year":"2017","journal-title":"Int. J. Parasitol."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320724000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320724000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T06:15:21Z","timestamp":1723011321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320724000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":34,"alternative-id":["S2211320724000277"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2024.100546","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robenidine derivatives as potential antischistosomal drug candidates","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2024.100546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100546"}}